As Abbvie Common Stock (ABBV) Market Value Declined, Holder Financial Engines Advisors Lowered Its Position; As International Business Machs (IBM) Stock Value Declined, Beech Hill Advisors Trimmed Position

AbbVie Inc. (NYSE:ABBV) Logo

Financial Engines Advisors Llc decreased its stake in Abbvie Common Stock (ABBV) by 9.1% based on its latest 2018Q3 regulatory filing with the SEC. Financial Engines Advisors Llc sold 12,748 shares as the company’s stock declined 6.62% with the market. The institutional investor held 127,338 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $11.92 million, down from 140,086 at the end of the previous reported quarter. Financial Engines Advisors Llc who had been investing in Abbvie Common Stock for a number of months, seems to be less bullish one the $119.84 billion market cap company. The stock increased 0.63% or $0.5 during the last trading session, reaching $79.67. About 4.60 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since February 10, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 25/05/2018 – ASTRAZENECA PLC – IMFINZI MET SECOND PRIMARY ENDPOINT OF OVERALL SURVIVAL IN PHASE lll PACIFIC TRIAL; 05/04/2018 – BIOGEN: PRECISE TERMS OF PACT WITH ABBVIE ARE CONFIDENTIAL; 16/04/2018 – BIOTHERA PHARMACEUTICALS PRESENTS TRANSLATIONAL DATA FROM ONGOING CLINICAL TRIALS SHOWING IMPRIME PGG IN COMBINATION WITH MERCK’S KEYTRUDA® (PEMBROLIZUMAB) DRIVES INNATE AND ADAPTIVE IMMUNE; 26/04/2018 – ABBVIE 1Q ADJ. EPS $1.87, EST. $1.79; BOOSTS FORECAST; 13/04/2018 – AbbVie’s Humira Retail Sales Rose 0.4% in Latest Week: Symphony; 23/04/2018 – European Medicines Agency Validates Type Il Variation for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and Platinum Chemotherapy as First-Line Therapy in Metastatic Nonsquamous NSCLC, Based on Phase 3…; 06/04/2018 – INCYTE CORP – EDMC REVIEW OF PHASE 3 ECHO-301/KEYNOTE-252 STUDY EVALUATING EPACADOSTAT WITH KEYTRUDA DETERMINED STUDY DID NOT MEET PRIMARY ENDPOINT; 28/03/2018 – lmmunovaccine Announces Initiation of Patient Dosing in lnvestigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL; 23/04/2018 – AbbVie Bond Trading 2x Average; Clients Net Sellers; 05/04/2018 – Samsung Bioepis Settles Patent Disputes with AbbVie, Clearing the Way for the Commercialization of SB5 (Adalimumab) in All

Beech Hill Advisors Inc decreased its stake in International Business Machs (IBM) by 86.8% based on its latest 2018Q3 regulatory filing with the SEC. Beech Hill Advisors Inc sold 26,971 shares as the company’s stock declined 16.83% with the market. The institutional investor held 4,100 shares of the computer manufacturing company at the end of 2018Q3, valued at $620,000, down from 31,071 at the end of the previous reported quarter. Beech Hill Advisors Inc who had been investing in International Business Machs for a number of months, seems to be less bullish one the $121.52B market cap company. The stock increased 0.39% or $0.52 during the last trading session, reaching $133.71. About 3.25 million shares traded. International Business Machines Corporation (NYSE:IBM) has declined 21.12% since February 10, 2018 and is downtrending. It has underperformed by 21.12% the S&P500. Some Historical IBM News: 17/04/2018 – IBM – FOR THE FIRST QUARTER OF 2018, PRE-TAX INCOME WAS $1.1 BILLION AND NET INCOME FROM CONTINUING OPERATIONS WAS $1.7 BILLION; 20/03/2018 – IBM Tool Seeks to Bridge AI Skills Gap; 03/04/2018 – IBM Selects FANDOM SPORTS for Exclusive Blockchain Digital Mentorship Program; 20/03/2018 – Zerto Partners with IBM to Provide Data Protection for IBM’s Resiliency Orchestration DRaaS Solution; 17/04/2018 – OpenSource: SCO Amends IBM Complaint Again; 15/05/2018 – Berkshire Exits IBM, Cuts Wells Fargo, Buys More Apple: 13F; 15/05/2018 – Squarepoint Ops Adds Garmin, Exits IBM, Buys More Lululemon: 13F; 02/04/2018 – Flashpoint Accelerates Channel and Strategic Partner Initiatives; Appoints Former IBM Executive Jeff Seifert as Global Channel; 17/04/2018 – Bloomberg TV: Breaking down IBM’s first-quarter results; 17/04/2018 – IBM Turnaround Questioned on Slower Growth of New Businesses

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 106 analyst reports since July 21, 2015 according to SRatingsIntel. Barclays Capital downgraded AbbVie Inc. (NYSE:ABBV) rating on Tuesday, December 1. Barclays Capital has “Equal-Weight” rating and $72 target. The firm earned “Buy” rating on Friday, October 23 by UBS. BMO Capital Markets maintained the shares of ABBV in report on Wednesday, October 11 with “Hold” rating. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Piper Jaffray on Thursday, September 28. The firm earned “Outperform” rating on Wednesday, October 11 by Cowen & Co. Credit Suisse maintained it with “Hold” rating and $7400 target in Thursday, July 20 report. The stock of AbbVie Inc. (NYSE:ABBV) has “” rating given on Monday, September 28 by Citigroup. As per Tuesday, March 15, the company rating was initiated by Deutsche Bank. The firm has “Outperform” rating given on Monday, October 30 by Leerink Swann. The rating was initiated by SunTrust on Wednesday, July 22 with “Buy”.

Since August 17, 2018, it had 0 buys, and 6 insider sales for $26.66 million activity. Shares for $3.82 million were sold by Gosebruch Henry O on Thursday, November 29. $4.88 million worth of AbbVie Inc. (NYSE:ABBV) was sold by SEVERINO MICHAEL. CHASE WILLIAM J sold $5.40M worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, December 12. 25,000 shares valued at $2.25M were sold by Schumacher Laura J on Friday, December 28.

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It is negative, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Bsw Wealth Partners holds 0.13% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 3,576 shares. Raab & Moskowitz Asset Mgmt Limited reported 12,563 shares. Puzo Michael J reported 17,176 shares. Zwj Investment Counsel reported 29,166 shares. Orleans Mgmt La accumulated 36,082 shares or 2.34% of the stock. Voya Investment Mgmt Limited Liability Co invested in 869,331 shares. 68,185 are owned by Carret Asset Mngmt Limited. Moreover, Bbr Prtnrs Limited Liability Corp has 0.56% invested in AbbVie Inc. (NYSE:ABBV). Lakeview Capital Prtn Llc invested in 0.26% or 4,243 shares. Gillespie Robinson & Grimm, a Connecticut-based fund reported 5,853 shares. Independent Invsts, a New York-based fund reported 54,350 shares. Gamble Jones Investment Counsel accumulated 154,574 shares or 1.35% of the stock. Retirement Systems Of Alabama stated it has 0.43% in AbbVie Inc. (NYSE:ABBV). Callahan Advsrs Limited Liability Company stated it has 11,828 shares or 0.21% of all its holdings. Goldman Sachs Grp holds 0.32% or 13.28M shares in its portfolio.

Financial Engines Advisors Llc, which manages about $88.20B and $5.24 billion US Long portfolio, upped its stake in Schwab Strategic Trust (SCHH) by 2.60 million shares to 8.70M shares, valued at $362.83 million in 2018Q3, according to the filing. It also increased its holding in Schwab Strategic Trust (SCHE) by 895,159 shares in the quarter, for a total of 5.74 million shares, and has risen its stake in Olin Corp (NYSE:OLN).

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “Here’s Why AbbVie’s Stock Tanked in January – The Motley Fool” on February 09, 2019, also Fool.com with their article: “3 Things to Expect in AbbVie’s Q4 Earnings Update – Motley Fool” published on January 24, 2019, Fool.com published: “Better Buy: Johnson & Johnson vs. AbbVie – The Motley Fool” on February 02, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie’s Imbruvica flunks late-stage pancreatic cancer study – Seeking Alpha” published on January 18, 2019 as well as Fool.com‘s news article titled: “Better Buy: AbbVie vs. Johnson & Johnson – The Motley Fool” with publication date: January 20, 2019.

Investors sentiment increased to 0.91 in Q3 2018. Its up 0.01, from 0.9 in 2018Q2. It improved, as 65 investors sold IBM shares while 594 reduced holdings. 116 funds opened positions while 481 raised stakes. 492.69 million shares or 0.61% more from 489.70 million shares in 2018Q2 were reported. Bremer Tru Association has invested 0.34% of its portfolio in International Business Machines Corporation (NYSE:IBM). Brown Advisory owns 282,927 shares for 0.12% of their portfolio. Klingenstein Fields & Com Ltd holds 0.72% or 132,017 shares. Alpha Windward reported 1,483 shares. 10,286 are owned by Cim Invest Mangement. Jarislowsky Fraser Limited stated it has 0.03% of its portfolio in International Business Machines Corporation (NYSE:IBM). Marietta Prtn Limited Company holds 0.26% in International Business Machines Corporation (NYSE:IBM) or 5,745 shares. Perkins Coie Trust has 15,415 shares. Homrich Berg owns 8,323 shares. Lpl Fincl Ltd Limited Liability Company holds 0.07% in International Business Machines Corporation (NYSE:IBM) or 206,702 shares. Cadence National Bank Na holds 10,542 shares. Gabelli Funds Limited Liability Corporation holds 0.05% or 62,000 shares. Arizona State Retirement reported 239,064 shares or 0.34% of all its holdings. Fdx holds 4,799 shares. Edgewood Mngmt Ltd Llc holds 0% or 1,500 shares.

Beech Hill Advisors Inc, which manages about $252.81M and $192.85M US Long portfolio, upped its stake in Morgan Stanley (NYSE:MS) by 7,076 shares to 78,246 shares, valued at $3.64M in 2018Q3, according to the filing. It also increased its holding in Dowdupont Inc by 49,636 shares in the quarter, for a total of 54,086 shares, and has risen its stake in General Mtrs Co (NYSE:GM).

Among 35 analysts covering International Business Machines (NYSE:IBM), 14 have Buy rating, 5 Sell and 16 Hold. Therefore 40% are positive. International Business Machines had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Bank of America on Thursday, November 10. The company was maintained on Tuesday, October 20 by UBS. On Wednesday, October 14 the stock rating was initiated by Barclays Capital with “Underweight”. The company was initiated on Friday, October 16 by Cantor Fitzgerald. The firm has “Hold” rating by Oppenheimer given on Tuesday, July 18. RBC Capital Markets maintained it with “Hold” rating and $16000 target in Wednesday, July 19 report. The company was maintained on Friday, July 14 by Drexel Hamilton. Citigroup maintained it with “Neutral” rating and $165 target in Wednesday, October 18 report. The firm has “Hold” rating given on Tuesday, August 22 by KeyBanc Capital Markets. The firm has “Sector Perform” rating given on Monday, January 18 by RBC Capital Markets.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Bizjournals.com which released: “IBM forecasts a federal market for weather model that uses smartphone data – Washington Business Journal” on January 14, 2019, also Fool.com with their article: “Forget Oracle, IBM Is a Better Value Stock – Motley Fool” published on January 31, 2019, Seekingalpha.com published: “IBM unveils power outage prevention tech – Seeking Alpha” on February 06, 2019. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Fool.com and their article: “This Could Be an Important Earnings Report for IBM – The Motley Fool” published on January 16, 2019 as well as Seekingalpha.com‘s news article titled: “IBM: Stay Calm, Stay Long – Seeking Alpha” with publication date: January 16, 2019.

International Business Machines Corporation (NYSE:IBM) Institutional Positions Chart

"

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.